A Registry Study to Evaluate Outcomes of PEMF Therapy in Subjects With Various Pain Etiologies
An Open-Label, Non-Controlled Study to Evaluate Outcomes of Pulsed Electromagnetic Field (PEMF) Therapy in Subjects With Various Pain Etiologies
Sponsor: Regenesis Biomedical, Inc.
Listed as NCT02881112, this NA trial focuses on Pain and remains completed. Sponsored by Regenesis Biomedical, Inc., it has been updated 12 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 7 earlier versions
-
May 2020 — Jan 2021 [monthly]
Completed NA
-
Dec 2019 — May 2020 [monthly]
Completed NA
-
Jun 2018 — Dec 2019 [monthly]
Completed NA
-
Dec 2017 — Jun 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Oct 2017 — Dec 2017 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Feb 2017 — Oct 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Mar 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Regenesis Biomedical, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .